Prelude Capital Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,538
Closed -$215K 1422
2025
Q2
$215K Buy
+13,538
New +$202K 0.02% 783
2024
Q4
Sell
-22,601
Closed -$612K 1603
2024
Q3
$612K Buy
+22,601
New +$577K 0.04% 542
2024
Q2
Sell
-10,446
Closed -$347K 1540
2024
Q1
$347K Buy
+10,446
New +$357K 0.02% 826
2023
Q4
Sell
-7,413
Closed -$253K 1391
2023
Q3
$253K Buy
+7,413
New +$282K 0.02% 768
2022
Q1
Sell
-5,761
Closed -$321K 2297
2021
Q4
$321K Sell
5,761
-3,718
-39% -$204K 0.01% 1277
2021
Q3
$550K Sell
9,479
-3,672
-28% -$226K 0.01% 844
2021
Q2
$833K Buy
13,151
+8,922
+211% +$588K 0.02% 707
2021
Q1
$270K Buy
+4,229
New +$245K 0.01% 1197
2020
Q2
Sell
-1,316
Closed -$51K 2301
2020
Q1
$51K Buy
+1,316
New +$67.1K ﹤0.01% 753
2019
Q4
Sell
-608
Closed -$32K 2307
2019
Q3
$32K Sell
608
-387
-39% -$20.8K ﹤0.01% 1303
2019
Q2
$58K Sell
995
-205
-17% -$11K ﹤0.01% 1081
2019
Q1
$60K Sell
1,200
-16,117
-93% -$710K ﹤0.01% 1077
2018
Q4
$644K Buy
+17,317
New +$630K 0.04% 402
2018
Q1
Sell
-4,800
Closed -$316K 1751
2017
Q4
$316K Buy
+4,800
New +$305K 0.03% 519
2015
Q4
Sell
-16,460
Closed -$832K 1717
2015
Q3
$832K Buy
+16,460
New +$877K 0.12% 203
2015
Q2
Sell
-2,001
Closed -$102K 2085
2015
Q1
$102K Buy
2,001
+1,061
+113% +$54.7K 0.01% 997
2014
Q4
$50K Sell
940
-567
-38% -$28.9K 0.01% 1236
2014
Q3
$69K Buy
1,507
+573
+61% +$27K 0.01% 1265
2014
Q2
$44K Sell
934
-99
-10% -$4.61K 0.01% 1416
2014
Q1
$48K Buy
+1,033
New +$47.8K 0.01% 1324
2013
Q4
Sell
-150
Closed -$7K 1960
2013
Q3
$7K Buy
+150
New +$6.4K ﹤0.01% 1383

Other funds holding XRAY

Prelude Capital Management's XRAY Position: Q3 2025 in Review

Prelude Capital Management sold out of Dentsply Sirona (XRAY) in Q3 2025, closing a stake of 13,538 shares — an estimated $215K sold.

Prelude Capital Management first reported a position in XRAY in Q3 2013 and held it in 21 quarters. The position peaked at $833K in Q2 2021. 411 funds tracked by Wall St. Rank hold XRAY as of Q3 2025.

  • Prelude Capital Management reported no remaining Dentsply Sirona position as of Q3 2025 after selling out during the quarter.
  • Prelude Capital Management sold 13,538 Dentsply Sirona shares in Q3 2025, an estimated $215K.
  • Prelude Capital Management first reported a position in Dentsply Sirona in Q3 2013 and held it in 21 quarters.
  • Prelude Capital Management's Dentsply Sirona position peaked at $833K in Q2 2021.
  • 411 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2025.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.